Endovascular Management of Symptomatic Carotid Artery Stenosis in a Patient with Thrombocytopenia

Abstract

Background Various medical comorbidities such as thrombocytopenia can be obstacles for managing patients with carotid artery disease.

Patient We describe our experience with urgent carotid artery stenting for symptomatic carotid artery stenosis in a patient with severe thrombocytopenia. During the treatment, several issues such as mechanism of infarction in carotid artery stenosis, timing of endovascular intervention, and decision making for intervention in patients with thrombocytopenia were discussed. Although the patient experienced complications after carotid artery stenting, he recovered with only mild sequelae.

Results and Conclusion Timely decision is required and individualized treatment strategies should be considered to achieve good results under the given conditions.

Keywords

cerebral ischemia - endovascular treatment - endovascular stent - stroke

• References

• 1 Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. National Institute of Neurological Disorders and Stroke Stroke and Trauma Division. North American Symptomatic Carotid Endarterectomy Trial (NASCET) investigators. Stroke 1991; 22 (6) 816-817
• 2 Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC ; German Stroke Study Collaboration. Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005; 62 (3) 393-397
• 3 Bates ER, Babb JD, Casey Jr DE , et al; American College of Cardiology Foundation Task Force; American Society of Interventional & Therapeutic Neuroradiology; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society for Interventional Radiology. ACCF/SCAI/SVMB/SIR/ASITN 2007 Clinical Expert Consensus Document on carotid stenting. Vasc Med 2007; 12 (1) 35-83
• 4 Lewis BE, Rangel Y, Fareed J. The first report of successful carotid stent implant using argatroban anticoagulation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome: a case report. Angiology 1998; 49 (1) 61-67
• 5 Moretti C, Teresa Lucciola M, Morena L , et al. Idiopathic thrombocytopenic purpura and percutaneous coronary stenting: a dangerous duo?. Int J Cardiol 2008; 130 (3) e96-e97
• 6 Stouffer GA, Hirmerova J, Moll S , et al. Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura. Catheter Cardiovasc Interv 2004; 61 (3) 364-367
• 7 Oliveira W, Meireles GC, Pimenta J. Elective coronary stent implantation in a patient with unstable angina and thrombocytopenia. J Invasive Cardiol 2005; 17 (7) 393-394
• 8 Brown MM. Should carotid stenting replace carotid endarterectomy in routine clinical practice?. Pract Neurol 2008; 8 (1) 39-45
• 9 Niccoli G, Burzotta F, Galiuto L, Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009; 54 (4) 281-292
• 10 Rerkasem K, Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke 2009; 40 (10) e564-e572
• 11 Abou-Chebl A, Reginelli J, Bajzer CT, Yadav JS. Intensive treatment of hypertension decreases the risk of hyperperfusion and intracerebral hemorrhage following carotid artery stenting. Catheter Cardiovasc Interv 2007; 69 (5) 690-696